Just came back from a research screening session for depression at the University of Washington. They’re testing iPad/iPhone video game(s) for their ability to help reshape the brain. (This is my hypothesis given that there are before and after MRIs.)
It was much longer than I expected … and the conversational history wasn’t that different from an intake session with a new therapist. Read that as HARD.
I am physically the most wrung out that I’ve been in a long time.
Continue reading “What does depression look (and feel) like?”
Seven months after the French government banned Allergan textured breast implants, the FDA has followed suit in the United States.
Allergan pulled all BioCell textured breast implant products from Europe last year and from Canada in May.
Continue reading “FDA joins France in banning Allergan textured breast implants”
I’m starting something today that I’ve known I should do for a while. But have been unable to force myself to do.
Last month my oncologist and I talked about depression. I wanted to see a psychologist who had experience with PTSD and EMDR because I’ve been down this road before.
She put in an expedited request.
Continue reading “Another cancer side effect: depression”
The Food and Drug Administration has approved Piqray (alpelisib) tablets to treat men and postmenopausal women whose advanced breast cancer is hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and PIK3CA-mutated.
Piqray is to be used in combination with the FDA-approved endocrine therapy fulvestrant. The PIK3CA-mutated, advanced or metastatic breast cancer (as detected by an FDA-approved test) is indicated following progression on or after an endocrine-based regimen.
Continue reading “FDA approves new drug to treat advanced breast cancer”